All posts
14550 total · page 24 of 291
Dr. Bhakti Yadav – Indore's 'Doctor Didi' and Pioneer of Compassionate Care
Molbio Diagnostics Targets ₹940 Crore in Ambitious IPO
Molbio Diagnostics seeks to raise ₹940 crore through IPO for expansion and promoter stake reduction.
Docon Sells 9.9% Stake in Thyrocare for Rs 986 Crore
Docon Technologies divests nearly 10% of Thyrocare, dropping its stake to 51.02%.
Surrogate Birth Sparks Legal Battle with Biological Parents
A surrogate in Texas gave birth amid a legal battle with biological parents over a termination request.
Medical Device Industry Challenges Draft Bill's Pharma-Like Regulations
India's medical device sector opposes the 2026 draft bill treating devices like drugs, citing potential harm to innovation and investments.
Abhay Soi Criticizes Proposed Price Cap on Private Hospital Rooms
Max Healthcare's Abhay Soi argues against a price cap on hospital rooms, citing investment needs.
Dr. Sandhya Satish Khadse: A Distinguished Leader in Paediatrics, Neonatal Nutrition & Medical Education
Molbio Diagnostics Eyes ₹940 Crore Through IPO for Global Expansion
Molbio Diagnostics plans a ₹940 crore IPO to enhance capital and reduce promoter stake, aiming for long-term growth in the global diagnostics market.
Docon Technologies Sells 9.9% Stake in Thyrocare for ₹986 Crore
Docon Technologies divests 9.9% of its stake in Thyrocare, raising ₹986 crore through market transactions.
Surrogate Battles for Custody After Birth Amidst Legal Conflict
A surrogate mother is challenging the biological parents for custody after giving birth to a baby diagnosed with a severe heart defect.
Medical Device Industry Challenges Draft Bill on Regulatory Grounds
India's medical device sector opposes a draft bill equating devices with drugs, citing potential harm to innovation.
Abhay Soi Challenges Proposed Price Cap on Private Hospital Rooms
Max Healthcare's Abhay Soi argues against a room rent cap, citing investment needs.
Molbio Diagnostics Seeks ₹940 Crore in IPO to Boost Growth
Molbio Diagnostics plans a ₹940 crore IPO to fund expansion and reduce promoter stake. The firm's growth is driven by its tuberculosis test kits.
Docon Technologies Sells 9.9% Stake in Thyrocare for Rs 986 Crore
Docon Technologies offloads a 9.9% stake in Thyrocare Technologies, garnering Rs 986 crore through stock exchanges.
Surrogate Birth Sparks Legal Battle Over Child Custody
A surrogate mother is contesting custody after giving birth amid a legal dispute with the baby's biological parents.
Medical Device Firms Oppose Draft Bill Equating Them with Pharma
India's medical device sector criticizes a draft bill for treating devices like drugs, citing potential harm to innovation and investment.
Max Healthcare's Abhay Soi Criticizes Private Hospital Price Cap Proposal
Abhay Soi discusses the potential impact of a proposed price cap on private hospital room rates, emphasizing the need for investment-friendly policies.
Indian Neurologist Urges National Dialogue on Rural Emergency Care
A leading neurologist highlights the urgent need for a national dialogue to address the emergency healthcare crisis in rural India.
Neurologist Shares Essential Tips for Maintaining Brain Health
A neurologist offers practical advice on keeping your brain healthy, emphasizing diet, exercise, and mental stimulation.
The Misunderstood Reality of Functional Neurological Disorder
Functional Neurological Disorder, a prevalent yet misunderstood brain disorder, challenges both patients and medical professionals with its complex symptoms.
Citius Oncology Announces Q3 2026 Financial Results and Business Developments
Citius Oncology reveals its fiscal Q3 2026 financial performance and strategic updates.
Taiho Oncology's REZILIENT3 Trial Yields Promising Results
Taiho Oncology's REZILIENT3 trial shows positive outcomes, advancing cancer treatment options.
Viagra's Potential in Halting Cancer Spread Unveiled by Researchers
Viagra may help reduce cancer spread by targeting a newly discovered mechanism, offering a novel approach in oncology.
Molbio Diagnostics IPO: A High-Risk Bet for Long-Term Gains?
Molbio Diagnostics seeks ₹940 crore through IPO, aiming to fund expansion and reduce promoter stake.
Thyrocare Promoter Sells 9.9% Stake for Rs 986 Crore
Docon Technologies offloaded a significant stake in Thyrocare, reducing its holding to 51.02%.
Surrogate Birth Sparks Legal Battle Over Custody After Medical Dispute
A surrogate mother is contesting custody after giving birth in Texas amid a conflict over the baby's health diagnosis.
Medical Device Industry Criticizes India's Draft Regulation Bill
India's medical device industry opposes a 2026 bill treating devices like drugs, citing potential harm to innovation and investment.
Abhay Soi Challenges Price Cap on Private Hospital Rooms
Max Healthcare's Abhay Soi argues against capping private hospital room rents, citing investment needs.
Cardiologist Questions Trump's Health Management Amid Scrutiny
A cardiologist raises seven concerns about former President Trump's healthcare, sparking debate over his medical regimen.
Cardiologist Highlights 6 Key Signs Your Heart Might Be in Trouble
Experiencing a racing heart after coffee? A cardiologist outlines six symptoms that could indicate serious heart issues.
Activist Devendra Mahto Requests Medical Clearance for Protest Return
Activist Devendra Mahto seeks approval from a civil surgeon to resume his protest activities.
Exploring Obsession: The Monster and the Surgeon Reviewed
The Guardian's review delves into a gripping tale of obsession and surgery, challenging readers with its intense narrative.
Surgeon Vice Admiral Arti Sarin Reflects on Military Medical Service
Surgeon Vice Admiral Arti Sarin shares insights from her four decades in military healthcare.
Molbio Diagnostics IPO Targets ₹200 Crore for Expansion
Molbio Diagnostics plans to raise ₹200 crore through an IPO, aiming to expand its manufacturing and reduce promoter stakes.
Docon Technologies Sells 9.9% Stake in Thyrocare for Rs 986 Crore
Docon Technologies sold a 9.9% stake in Thyrocare Technologies for Rs 986 crore to institutional investors via NSE and BSE.
Silent Threat: Importance of Early Lung Cancer Screening
Lung cancer often goes undetected for years. Early screening is vital for those at risk, especially smokers and older adults.
High-Fat Diet Linked to Increased Colorectal Cancer Risk
New research highlights the link between high-fat diets and a higher risk of colorectal cancer.
Surrogate Fights for Custody After Giving Birth Amid Legal Dispute
A surrogate in Texas battles for custody after biological parents sought to terminate the pregnancy due to a fetal heart defect.
Medical Device Industry Opposes Draft Bill, Cites Regulatory Concerns
India's medical device sector contests the draft bill equating devices with drugs, fearing stifled innovation and investment.
Abhay Soi Criticizes Proposed Price Caps on Private Hospitals
Max Healthcare's Abhay Soi argues against capping room prices, citing investment needs.
Molbio Diagnostics IPO: A High-Risk Bet for Long-Term Growth?
Molbio Diagnostics aims to raise ₹200 crore for expansion while reducing promoter stake through a ₹740 crore offer for sale.
Docon Technologies Sells 9.9% Stake in Thyrocare for Rs 986 Crore
Docon Technologies divests a 9.9% stake in Thyrocare, raising Rs 986 crore through NSE and BSE transactions.
Surrogate Birth Sparks Legal Battle with Biological Parents
A surrogate mother is fighting for custody after giving birth amid a dispute over a pregnancy termination request.
Medical Device Firms Challenge Draft Bill's Pharma-Like Regulations
India's medical device sector opposes a draft bill treating devices like drugs, citing risks to innovation and investment.
Abhay Soi Challenges Proposed Cap on Private Hospital Room Rates
Max Healthcare's Abhay Soi argues against a blanket cap on private hospital room rates, citing investment viability concerns.
Docon Sells 9.9% Stake in Thyrocare for Rs 986 Crore
Docon Technologies offloaded nearly 10% of its stake in Thyrocare Technologies, raising Rs 986 crore through NSE and BSE deals.
Medical Device Industry Rejects Draft Bill's Pharma Approach
India's medical device sector opposes a draft bill equating devices with drugs, citing risks to innovation.
Abhay Soi Criticizes Price Caps on Private Hospital Rooms
Max Healthcare's Abhay Soi argues that price caps on hospital rooms could hinder investment in new facilities.
Docon Sells 9.9% Stake in Thyrocare for Rs 986 Crore
Docon Technologies offloaded a 9.9% stake in Thyrocare, raising Rs 986 crore through NSE and BSE transactions.
Molbio Diagnostics' Shares Surge Over 21% in Stock Market Debut
Molbio Diagnostics' shares soared over 21% in their market debut, following strong demand in its IPO.